Test Center

My Recent Searches

  • No Recent Search.

My Tests Viewed

  • No Test Viewed.

Showing search results for "thyroid cancer" 11-20 of 84

  1. Neuron Specific Enolase (NSE)

    Provides a brief overview of this test including clinical use and background, methodology, test interpretation, and specimen requirements.... More

  2. Polycystic Ovary Syndrome (PCOS)

    This Clinical Focus provides information on tests available for the differential diagnosis of polycystic ovary syndrome (PCOS) and the identification of common comorbidities.... More

  3. Paraneoplastic Neurological Syndromes: Laboratory Support of Diagnosis

    This Clinical Focus discusses the role of autoantibody testing in the diagnosis of paraneoplastic neurological syndromes and associated tumors.... More

  4. Alpha Subunit

    This test is used to diagnose and manage pituitary, placental, and pancreatic tumors.... More

  5. Lung Cancer (NSCLC), ROS1 (6q22) Rearrangement, FISH

    This test is used to assess potential for response to crizotinib therapy in patients with non-small cell lung cancer (NSCLC).... More

  6. Bladder Cancer, FISH

    This test can be used to help diagnose bladder cancer in patients with hematuria and to detect bladder cancer recurrence.... More

  7. Lung Cancer Mutation Panel (EGFR, KRAS, ALK)

    This test can be used to help predict the likelihood of response or resistance to targeted therapies (eg, erlotinib, gefitinib) and to assess eligibility for treatment with crizotinib (Xalkori) in patients with non-... More

  8. Carcinoembryonic Antigen (CEA)

    This test is used for detecting recurrence and monitoring therapy for patients with colon cancer. Recommendations from the American Society of Clinical Oncology and the National Comprehensive Cancer Network for the use ... More

  9. CA 125

    This test is used in therapeutic monitoring of patients with ovarian cancer, residual disease detection in patients with epithelial ovarian cancer, and early detection of ovarian cancer recurrence.... More

  10. Genetic Testing Criteria for HBOC Syndrome

    This document summarizes the National Comprehensive Cancer Network (NCCN) genetic testing criteria for hereditary breast and ovarian cancer syndrome. That is, it provides patient eligibility criteria for BRCA1/BRCA2 ... More

* The tests listed by specialist are a select group of tests offered. For a complete list of Quest Diagnostics tests, please refer to our Directory of Services.